Is this the right MOMENTUM?-evidence from a HeartMate 3 randomized trial.
作者信息
Mariani Silvia, Chatterjee Anamika, Hanke Jasmin S, Homann Katharina, Dogan Günes, Haverich Axel, Schmitto Jan D
机构信息
Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany.
出版信息
J Thorac Dis. 2019 Dec;11(12):5626-5630. doi: 10.21037/jtd.2019.11.60.
Abstract
摘要
相似文献
1
Is this the right MOMENTUM?-evidence from a HeartMate 3 randomized trial.这是合适的时机吗？——来自HeartMate 3随机试验的证据。
J Thorac Dis. 2019 Dec;11(12):5626-5630. doi: 10.21037/jtd.2019.11.60.
2
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.磁悬浮技术在使用HeartMate 3进行机械循环支持治疗的患者中的多中心研究（MOMENTUM 3）研究性器械豁免临床试验方案的临床试验设计与原理。
J Heart Lung Transplant. 2016 Apr;35(4):528-36. doi: 10.1016/j.healun.2016.01.021. Epub 2016 Jan 30.
3
Correction to: Letter by Consolo and Pappalardo Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".对以下信件的更正：康索洛和帕帕拉多就文章《MOMENTUM 3研究长期队列中中风的综合分析：Heartmate 3与Heartmate II心脏泵的随机对照试验》所写的信件。
Circulation. 2019 Oct 15;140(16):e728. doi: 10.1161/CIR.0000000000000737. Epub 2019 Oct 14.
4
Do patients with the centrifugal flow HeartMate 3 or HeartWare left ventricular assist device have better outcomes compared to those with axial flow HeartMate II?与使用轴流HeartMate II的患者相比，使用离心流HeartMate 3或HeartWare左心室辅助装置的患者是否有更好的治疗效果？
Interact Cardiovasc Thorac Surg. 2019 Dec 1;29(6):844-851. doi: 10.1093/icvts/ivz202.
5
Letter by Consolo and Pappalardo Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".康索洛和帕帕拉多就《MOMENTUM 3研究长期队列中中风的综合分析：Heartmate 3与Heartmate II心脏泵的随机对照试验》一文所写的信函。
Circulation. 2019 Jul 23;140(4):e163-e164. doi: 10.1161/CIRCULATIONAHA.119.040124. Epub 2019 Jul 22.
6
Response by Mehra and Colombo to Letter Regarding Article, "Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study: A Randomized Controlled Trial of the Heartmate 3 Versus the Heartmate II Cardiac Pump".梅赫拉和科伦坡对关于文章《MOMENTUM 3研究长期队列中卒中的综合分析：Heartmate 3与Heartmate II心脏泵的随机对照试验》的信件的回应
Circulation. 2019 Jul 23;140(4):e165-e166. doi: 10.1161/CIRCULATIONAHA.119.040736. Epub 2019 Jul 22.
7
Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.左心室辅助装置植入术后的右心功能障碍：搏动性HeartMate I与轴流式HeartMate II装置的比较
Ann Thorac Surg. 2008 Sep;86(3):832-40; discussion 832-40. doi: 10.1016/j.athoracsur.2008.05.016.
8
Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients.质量和功能容量的结果在时刻 3 试验 6 个月:呼吁新的指标为左心室辅助装置患者。
J Heart Lung Transplant. 2018 Jan;37(1):15-24. doi: 10.1016/j.healun.2017.10.019. Epub 2017 Oct 24.
9
Hemocompatibility-Related Outcomes in the MOMENTUM 3 Trial at 6 Months: A Randomized Controlled Study of a Fully Magnetically Levitated Pump in Advanced Heart Failure.MOMENTUM 3 试验 6 个月时的血液相容性相关结局：一种先进心力衰竭全磁悬浮泵的随机对照研究。
Circulation. 2017 May 23;135(21):2003-2012. doi: 10.1161/CIRCULATIONAHA.117.028303. Epub 2017 Apr 6.
10
The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD).HeartMate 3的发展态势：一种新型主动磁悬浮离心式左心室辅助装置（LVAD）
J Thorac Dis. 2018 Jun;10(Suppl 15):S1790-S1793. doi: 10.21037/jtd.2017.10.124.
本文引用的文献
1
Comparison of Neurologic Event Rates Among HeartMate II, HeartMate 3, and HVAD.心 II 号、心 3 号和 HVAD 之间神经事件发生率的比较。
ASAIO J. 2020 Jun;66(6):620-624. doi: 10.1097/MAT.0000000000001084.
2
Evaluation of a lateral thoracotomy implant approach for a centrifugal-flow left ventricular assist device: The LATERAL clinical trial.经外侧开胸入路植入离心式左心室辅助装置的评估：LATERAL 临床试验。
J Heart Lung Transplant. 2019 Apr;38(4):344-351. doi: 10.1016/j.healun.2019.02.002.
3
A Fully Magnetically Levitated Left Ventricular Assist Device - Final Report.全磁悬浮左心室辅助装置 - 最终报告。
N Engl J Med. 2019 Apr 25;380(17):1618-1627. doi: 10.1056/NEJMoa1900486. Epub 2019 Mar 17.
4
The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships.胸外科医师学会 Intermacs 数据库年度报告：不断演变的适应证、结果和科学合作。
J Heart Lung Transplant. 2019 Feb;38(2):114-126. doi: 10.1016/j.healun.2018.11.013.
5
Comprehensive Analysis of Stroke in the Long-Term Cohort of the MOMENTUM 3 Study.《MOMENTUM 3 研究长期队列中的卒中综合分析》
Circulation. 2019 Jan 8;139(2):155-168. doi: 10.1161/CIRCULATIONAHA.118.037231.
6
Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry.HeartMate 3 左心室辅助装置的上市后经验：ELEVATE 注册研究的 30 天结果。
Ann Thorac Surg. 2019 Jan;107(1):33-39. doi: 10.1016/j.athoracsur.2018.07.092. Epub 2018 Oct 3.
7
A tale of the twist in the outflow graft: An analysis from the MOMENTUM 3 trial.流出道移植物扭曲的故事：来自MOMENTUM 3试验的分析
J Heart Lung Transplant. 2018 Nov;37(11):1281-1284. doi: 10.1016/j.healun.2018.08.011. Epub 2018 Aug 24.
8
An international multicenter experience of biventricular support with HeartMate 3 ventricular assist systems.国际多中心 HeartMate 3 心室辅助系统的双心室支持经验。
J Heart Lung Transplant. 2018 Dec;37(12):1399-1402. doi: 10.1016/j.healun.2018.08.008. Epub 2018 Aug 17.
9
Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.完全磁悬浮循环支持装置治疗晚期心力衰竭的长期评估——HeartMate 3 CE 标志研究的两年结果。
Eur J Heart Fail. 2019 Jan;21(1):90-97. doi: 10.1002/ejhf.1284. Epub 2018 Jul 27.
10
A new tool for an explantation strategy of HeartMate 3™ left ventricular assist device.用于HeartMate 3™左心室辅助装置植入策略的一种新工具。
J Thorac Dis. 2018 Jun;10(Suppl 15):S1825-S1828. doi: 10.21037/jtd.2018.04.57.
Zotero 插件